Description
Ocuvir SR 1.2gm Tablet is a prescription antiviral medicine containing Acyclovir 1200mg in a sustained-release formulation. It is used to treat infections caused by the Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV), including cold sores, genital herpes, shingles, and chickenpox. The sustained-release formulation provides prolonged drug release for effective viral suppression.
Uses of Ocuvir SR 1.2gm Tablet
- Herpes simplex infections
- Genital herpes
- Cold sores (Herpes labialis)
- Shingles (Herpes zoster)
- Chickenpox (Varicella)
- Prevention of recurrent herpes infections (as prescribed)
Benefits of Ocuvir SR 1.2gm Tablet
- Helps control herpes virus infections
- Reduces pain, itching, and blister formation
- Shortens the duration of viral infections
- Lowers the risk of complications
- Helps reduce recurrence of herpes infections when prescribed
How Ocuvir SR 1.2gm Tablet Works
Acyclovir works by blocking viral DNA replication, preventing the herpes virus from multiplying. This helps control the infection, reduces symptoms, and promotes faster healing.
Dosage
- Take Ocuvir SR 1.2gm Tablet exactly as prescribed by your doctor.
- Swallow the tablet whole with water.
- Do not crush, chew, or break the sustained-release tablet.
- Complete the full course of treatment.
How to Use
- Take the tablet with or without food.
- Drink plenty of water during treatment to help protect kidney function.
- Start treatment as early as possible after symptoms appear for the best results.
Side Effects
Common side effects include:
- Nausea
- Vomiting
- Headache
- Diarrhea
- Dizziness
- Abdominal pain
- Fatigue
Seek immediate medical attention if you experience severe allergic reactions, confusion, reduced urine output, or seizures.
Precautions
- Inform your doctor if you have kidney disease, liver disease, or a weakened immune system.
- Drink adequate fluids while taking this medicine.
- Use during pregnancy or breastfeeding only if prescribed.
- Avoid skipping doses to maintain effective antiviral action.
Leave a Reply